Curi Bio Launches Mantarray™ Platform – 3D Engineered Muscle Tissues
Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis.